Towards precision medicine in colorectal cancer liver metastases
- PMID: 32774838
- PMCID: PMC7399578
- DOI: 10.2217/hep-2020-0011
Towards precision medicine in colorectal cancer liver metastases
Keywords: KRAS; Liver metastases; colorectal cancer; precision medicine.
Conflict of interest statement
Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.
References
-
- Bray F, Ferlay J, Soerjomataram I. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA J. Clin. 68(6), 394–424 (2018). - PubMed
-
- van Cutsen E, Cervantes A, Nordlinger B. et al. Metastatic colorectal cancer: ESMO clinical practice guidelines for diagnosis treatment follow-up. Ann. Oncol. 25(3), iii1–9 (2014). - PubMed
-
- Masuda T, Margonis GA, Andreatos N. et al. Combined hepatic resection and radio-frequency ablation for patients with colorectal cancer liver metastasis: a viable option for patients with a large number of tumors. Anticancer Res. 38(11), 6353–6360 (2018). - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous